-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Qualigen Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
- Qualigen Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $33.1K, a 63.9% decline year-over-year.
- Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.1M, a 80% decline from 2022.
- Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.48M, a 3.6% increase from 2021.
- Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.29M.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)